Findings: In this retrospective cohort study of 514,878 men with a PCa diagnosis from 2004-2012, we found that race had a significant impact in many age groups and disease stages. However, healthcare access and quality, and social factors had greater or similarly important effects across all ages and stages.
Introduction
African-American men, have a 1.6 times higher incidence of prostate cancer (PCa) and more than twice the rate of PCa mortality compared to white men in the United States. 1 PCa death rates have steadily declined since the 1990's, a phenomenon commonly attributed to improved diagnostic and treatment regimens. 2, 3 However, the African-American/white PCa mortality differential has slightly increased during this time, in contrast to a decrease in the differential for overall cancer mortality. 4 Genetic differences in PCa susceptibility are not likely to contribute to increasing disparities. It is more likely a combination of genetic and environmental factors, including underlying social and healthcare factors.
Genetic differences in PCa susceptibility and tumor behavior have been associated with increased PCa mortality for African-American men. African-American men show differences in TGFβ signaling 5 and an increased rate of susceptibility loci associated with PCa. 6 Additionally, African-American individuals have higher prostate-specific antigen (PSA) values for equivalently staged cancer. 7 Those with very low-risk disease have been shown to have an increased risk of clinical upstaging or progression to treatment on active surveillance, 8 as well as adverse pathology after prostatectomy. 9 Racial disparities for PCa due to exogenous factors, such as healthcare access and quality have also been well documented. 10 Compared to White men, African-American men have been shown to have higher stage disease at the time of diagnosis, 11 particularly among younger age groups. 12 While some studies find that racial differences in survival can be explained by access to care and sociodemographic variables, 13, 14 other find these factors are only partial mediators. 15, 16 Fully understanding the interplay between biologic and social factors and their respective contribution to the observed differences in mortality is essential for reducing racial disparities in prostate cancer mortality.
Minimizing racial disparities due to genetic differences requires individualized racespecific and genetic approaches to care, while decreasing the social and healthcare factors requires more equitable distribution of resources. A firmer understanding of the impact and complex interplay of disease-specific characteristics, race, healthcare access and quality, and other social factors are necessary to identify the determining factors for prostate cancer mortality and to improve outcomes for African-American men. Identifying the most important factors for predicting prostate cancer mortality requires methodological approaches that take into account multiple variables (and their interactions) simultaneously, as each factor may be highly correlated and create heretofore unappreciated synergies.
Using patient cohorts from the Surveillance Epidemiology and End-Results (SEER)
database, we take advantage of random forest regression, a supervised machine learning method, to identify the factors that are strong predictors of prostate cancer mortality. These methods allow measurement of the relative importance of each factor while exploring all possible interactions and selection of the most predictive factors. We hypothesize that tumor characteristics (Gleason score and PSA) will be the strongest predictors of PCa mortality among all stages of disease. We also hypothesize that race will have a measurable impact on lethality in many age groups and disease stages, although it will have a relatively smaller impact compared to tumor characteristics, and healthcare factors (access and quality) and social factors (median family income, population density, and social vulnerability), will be similarly impactful compared to race.
Methods

Data source
Data for this study are captured by the 18 registries comprising the Surveillance, 17 PSA values were grouped into <4ng/mL, 4-10ng/mL, 10-20ng/mL, and >20ng/mL.
Measures of access to healthcare at the county level were drawn from the AHRF database and included number of physicians, radiation oncologists, urologists, and number of chemotherapy treatment centers. We compared counties with one or more urologists to those with none. 14, 15 We expected a non-linear relationship between physician density and PCa mortality; therefore, we compared counties in the 25 th and 75 th percentiles to the middle 50% of the distribution. The AHRQ Prevention Quality Indicator (PQI) was used to measure the quality of ambulatory care in the county.
Social factors that may affect prostate cancer mortality were derived from multiple sources. Rural/Urban designation was identified from the AHRF. County-level median family income collected from the 2000 U.S. Census was also included in the models. We also considered the proportion of the Medicare population in each county that is also eligible for
Medicaid enrollment ("dual enrollees"). 18 The CDC Social Vulnerability Index (SVI) was included in the models. 18 SVI measures the resilience of communities when confronted by external stresses on human health, stresses such as natural or human-caused disasters, or disease outbreaks. 18 
Statistical Methods
Random forests (RF) are an extension of Classification and Regression Tree (CART) modeling. In this method, n trees are grown using bootstrapped samples from the learning sample. 19, 20 As these trees are grown each branch point, called a node, occurs to separate the groups based on the factor that best explains the variability in mortality within the group. For example if Gleason score of >8 explains more of the variance in mortality identified within the group compared to PSA values >20 then at the next node the single group will separate into two groups based on Gleason score, regardless of PSA values and other factors. Unlike CART, there is no trimming or stopping criterion, the trees are fully grown. Additionally, a random subset of variables is selected for inclusion at each node. This method of random subspace selection is done to avoid correlation between trees in the forest and decreases the risk of multicollinearity. It also allows for the identification of the most relevant variables when multicollinearity is present and therefore reduces the variables of interest to those with the most explanatory value. 21 One benefit of the RF method is the ability to quantify the variable importance.
Since each tree is a random 70% subset of the original dataset, the remaining 30% of the data not selected (e.g., out of bag observations (oob)) can be used to calculate the variable importance. The oob data is used to create permutation accuracy variable importance measure (VIMP) by predicting class membership in the oob sample and then randomly permuting the values and calculating the decrease in predictive accuracy with permuted variables (it is also known as the Mean Decrease in Accuracy (MDA) measure). The average difference in accuracy of the oob versus permuted oob observations over all trees is the VIMP, with a VIMP close to zero implying that the variable has no predictive power.
Models were stratified by age at diagnosis (40 -54, 55 -69, and 70+) and stage at diagnosis (Stage I/II, Stage III, and Stage IV). This allowed us to look for differences within stage of diagnosis, therefore netting out racial differences in prostate cancer survival due to stage at diagnosis. All analyses were run in R using the randomForestSRC and survival packages. We performed our analysis with a subset of the sample in which all African-American individuals were matched to a non-Hispanic white counterpart by birth year, stage at diagnosis, and age at diagnosis. This approach allowed us to compare the importance of the variables without it being biased by the unequal distribution of race in the total population as well as directly compare non-Hispanic whites to African-Americans.
We included a total of 15 variables in each model. For descriptive purposes, variables were binned into four broad categories; tumor characteristics, social factors, healthcare factors, and race. To create a measure of relative importance, VIMPs were summed across categories and then compared to the sum of tumor characteristic VIMPs in order to standardize the measure across models stratified by age and stage. We then repeated these analyses with the total patient cohort to measure the impact of race more broadly.
Results
Descriptive statistics of all 15 variables are displayed in Table 1 by age at diagnosis.
PCa was diagnosed in 55,493 men ages of 40-54, 282,358 men ages 55-69, and 174,213 ages 70+. There was more racial heterogeneity in the youngest age groups relative to men 70+. Men in the 40-54 age category were also more likely to have a lower stage and grade at diagnosis, and reside in higher income, metropolitan counties. Across both analyses and all stages and age groups, race was never greater than 1/20th as important as tumor characteristics. In fact, in many subgroups, particularly among younger patients and stage 4 disease, race was not a measurably important factor for mortality. Race was only more important than healthcare and social factors for 2 of the 18 groups from our analyses (stage 3, age 55-69 and 70+ in the matched subset analysis). Comparatively, healthcare factors were important predictors of prostate cancer mortality across all ages and stages and social factors were important predictors of mortality among every group except the stage 3, 40-54 age group in the matched subset analysis.
There are interesting differences in the pattern of variable importance in the overall cohort compared to the matched subset. For the matched subset, social factors are more important in lower stages for men age 55-69 and in general, factors other than tumor characteristics are less important as stage increases. Comparatively, in the full cohort, healthcare and social factors are less important relative to tumor characteristics at lower stages of the disease and in general these factors increase in importance as stage increases, particularly among the younger age groups.
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Discussion
Tumor characteristics were the most important factors for predicting prostate cancer mortality for all ages and stages. All other factors combined ranged from 1/4 th to 1/10 th as important when directly compared to tumor characteristics. Healthcare factors, social factors and race were important predictors of prostate cancer mortality, but the relative importance varied between the different age groups and disease stages. While race was a measurably important factor in predicting prostate cancer mortality, the healthcare and social factors (factors also known to associated with racial disparities) were more important for all but 2 of the 18 groups in our analysis.
The low importance of race in this analysis brings to question the benefit of differential treatment for African-American men regarding prostate cancer. Many experts have included African-American race as an independent risk factor with prostate cancer management, potentially exposing them to variations in screening or treatment based on these risks. [22] [23] [24] Personalized medicine has largely focused on the biological variables that can be used to individualize health outcomes, but personalized medicine that fails to incorporate the framework of socially based health disparities will likely fail to improve outcomes. 25 The overall effect of race as a determinant of prostate cancer outcomes is not solely biological, but instead may be tied to the social milieu that is often tied to health outcomes in general. Patient genetics and tumor biology among African-American patients are inextricably linked to a population with poorer health access and less resources. 26 Leveraging random forests, we were able to disentangle the complex interplay of tumor, race, healthcare and social factors. Traditional regression approaches, which require all interactions be specified a priori are not well suited for the exploratory analyses needed to identify variables involved in the complex interplay between the individual and broader social context. When disentangling biology from social and healthcare factors using traditional regression methods one needs to specify interactions to test for differences in the effect of individual and neighborhood characteristics on prostate cancer mortality and predetermine the number of interactions. Fundamentally interactions involving multiple variables are difficult to interpret and introduce multicollinearity.
Random forests allow us to explore the complex associations between multiple variables and measure the importance of each variable in predicting prostate cancer mortality. This highly predictive modeling approach considers all possible combinations of variable interactions and addresses multicollinearity issues. This data driven, "reverse-engineering" approach allows us to disentangle the role of individual and neighborhood factors that are correlated with race/ethnicity and identify the strength of their contribution to driving prostate cancer outcomes.
These models are known to have better predictive power than traditional regression methods and can identify complex hidden relationships in the data, especially for questions such as this where there is high collinearity between measures and decomposition of the importance of the effects is difficult. 27 There are significant challenges to measuring the impact of race on prostate cancer mortality and it is important to note that the methods used in this analysis are designed to optimize prediction and not assess causation. The predictability of our models, which ranged from 0.75 -0.85 for the different age groups and disease stages, suggests that the factors we considered explain a large amount of variation in prostate cancer mortality within this cohort.
These models suggest that while race is often an important predictor in prostate cancer mortality, risk is also tied up in social forces that influence these outcomes. Additionally, the slight variation between the matched subset analysis and the cohort overall suggests that the pattern of racial disparities among other groups may be different than those found for AfricanAmerican individuals. Whatever these specific patterns it is clear that one of the fundamental methods used to reduce racial disparities in prostate cancer outcomes has to involve an elimination of racial disparities for social and healthcare factors as well.
There are important considerations with the interpretation of our analyses. While it is likely that fundamental differences exist in regards to prostate cancer incidence and disease behavior, it is currently difficult for clinicians to incorporate race as a factor when clinically managing patients with a PCa diagnosis, particularly when considering confounding factors such as access and quality of care and the paucity of clinical research devoted to AfricanAmerican patients. Our analyses do not suggest that race is unimportant with regards to prostate cancer mortality in general. As our cohort consisted of patients already diagnosed with prostate cancer of a given stage, our analysis does not consider differences in incidence of prostate cancer or variation of stage at diagnosis between races, both of which are known disparities among African-Americans. 1, 11, 12 However, for a patient with equivalent disease specific factors it appears that healthcare access and quality and other social factors known to be associated with race are as important (if not more important) when considering risks for PCaspecific mortality.
This novel approach is an important step towards disentangling the relationship of biology and other factors with regards to race. While we cannot determine if each of the confounding factors associated with race (independent of biology or genetics) have been isolated in this analysis, the low impact of race in many of the patient age groups and stages suggests that many of factors associated with race and prostate cancer mortality have been identified and delineated. Our next step will be incorporation of incidence and stage at diagnosis in similar modeling and characterizing the importance healthcare and social factors associated with those racial disparities.
Conclusions
Attempting to reduce racial disparities through a personalized medicine driven approach without addressing racial disparities in social and healthcare factors may close the racial gap for the economically advantaged, while reinforcing disparities for the disadvantaged. Although race had a significant impact in many age groups and disease stages, healthcare factors and social factors had greater or similarly important effects across most stages and age groups. It is extremely difficult to completely disentangle these factors, however, a reduction in the disparities in social factors and access to healthcare may provide the largest gains in improving prostate cancer mortality and minimizing racial disparities. Prostate screening antigen at time of diagnosis was binned into the categories as well based on the American Urologic Association criteria ( <4, 4 -9.9, 10 -19.9, and 20+).
Selected county-level measures from the AHRF database included number of physicians and surgeons, radiation oncologists, urologists, and short-term general hospitals per 100,000 population.
We expected a non-linear relationship between physician density and PCa mortality; therefore, we compared counties in the 25 th and 75 th percentiles to the middle 50% of the distribution. Based on findings from other studies 14, 15 , we compared counties with one or more urologists to those with none.
The AHRF also includes a code for Metropolitan/Micropolitan Statistical Areas, with the following categories; 1) rural, 2) Metropolitan Statistical Areas having at least one urbanized area of 50,000 or more population, and 3) Micropolitan Statistical Areas having at least one urban cluster with a population of 10,000-50,000.
The Agency for Heathcare and Research Quality (AHRQ) Prevention Quality Indicator (PQI) was used to measure the quality of care for "ambulatory care sensitive conditions". This set of measures can be used with hospital inpatient discharge data to identify quality of care for "ambulatory care sensitive conditions." The PQIs are population based and adjusted for covariates. Even though these indicators are based on hospital inpatient data, they provide insight into the community health care system or services outside the hospital setting. For example, patients with diabetes may be hospitalized for diabetic complications if their conditions are not adequately monitored or if they do not receive the patient education needed for appropriate self-management.
County-level demographics from the 2000 U.S. Census were also included in the models.
Median-family-income (MFI) and the percent of families below the poverty line were also drawn from the Census data. As this population is largely over age 65, we considered the proportion of the Medicare population in each county that is also eligible for Medicaid enrollment ("dual enrollees").
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The Center for Disease Control (CDC) Social Vulnerability Index (SVI) was included in the models. The SVI uses 15 variables from the 2000 US Census data to measure four domains of social vulnerability; 1)
Socioeconomic status (income, poverty, employment, and education), 2) Household composition and disability (age, single parents, and disability), 3) Minority status and language profile (race, ethnicity, and English language), and 4) Housing and transportation profile (housing structure, crowding, and vehicle access). Counties are then given an overall vulnerability rank.
Statistical Methods
Classification and Regression Trees
Traditional regression approaches specify interactions to test for differences in the effect of individual, family history, and neighborhood characteristics on prostate cancer mortality. However, there are some limitations to using interactions to bin individuals into groups with similar prognostic outcomes. All interactions need to be specified a priori and the number of interactions and interactions involving multiple variables are difficult to interpret. A classification and regression tree (CART) is an alternative method that allows us to explore the structure of the data with the goal of predicting survival outcomes based on individual and county level characteristics that may affect prostate cancer mortality.
A regression tree is a hierarchal structure that has a top node (or root) and observations are passed down the tree. Each decision point, which is selected by the algorithm to explain the most deviance, is labeled a node (sometimes called daughter nodes) until it reaches a terminal node (or leaf).
CART uses a binary splitting process to identify the best model for classifying individuals into distinct groups. The central aim of the regression tree approach is to form meaningful classes that are determined by the data (not a priori assumptions). The results from CART likely do not represent additive functions that consist only of main effects, but complex interactions between variables in the data. Essentially, we are asking how a compilation of variables come together to define distinct subclasses of individuals.
Random Forest
Random forests (RF) are an extension of CART. In this method, n trees are grown using a bootstrapped sample from the learning sample. [2, 3] The number of trees grown is specified by the user, with a default of 1000 in the R statistical package randomForestSRC with a logrank splitting rule.
We chose to have the algorithm fit 200 trees and constrained the model to have a terminal node size of 50. Unlike CART, there is no trimming or stopping criterion, the trees are fully grown (the user can modify this criterion, however the standard practice is to fully grow the tree). Additionally, a subset of variables are randomly selected for inclusion at each node. This method of random subspace selection is done to avoid correlation between trees in the forest and decreases the error. It also allows for the selection of the most relevant variables when there are multicollinearity issues and therefore reduces the variables of interest to those with the most explanatory value. [4] All models had error rates that ranged between 17% and 29%, with the highest stage of disease models having the highest error rates.
One benefit of the RF method is the ability to quantify the variable importance. We used the Breiman-Cutler measure of importance (or permutation) measure, the most frequently used measure for random forests. Since each tree is a random subset of the original dataset, the remaining 30% of the data not selected (e.g., out of bag observations (oob)) can be used to calculate the variable importance.
The oob data is used to create permutation accuracy variable importance measure (VIMP) by predicting class membership in the oob sample and then permuting the variables and calculating the predictive accuracy with permuted variables. The average difference in accuracy of the oob versus permuted oob observations over the trees is the VIMP, with a VIMP close to zero implying that the variable has no predictive power. Correlation between variables was assessed to assure that none of the variables were highly (r>0.75) predictive of the variables in the model.
Cox Proportional Hazard Regression
Cox regression with all variables were also run for each age and stage model. These models only included main effects and, while the interpretation between RF and Cox PH models differs, were used to assess the benefit of using an RF approach. We found that there were substantive differences in interpretation between the RF and Cox PH mod 
